Evidence map›Paper›PMID 25815043›Full record

ArticleComputational and mathematical methods in medicine2015

A hybrid intelligent diagnosis approach for quick screening of Alzheimer's disease based on multiple neuropsychological rating scales.

Ziming Yin, Yinhong Zhao, Xudong Lu, Huilong Duan

Abstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ziming YinCollege of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, Zhejiang 31002, China.ORCID 0000-0002-7572-1748
Yinhong ZhaoChina National Center for Biotechnology Development, Building D, No. 16, Xisihuanzhonglu, Haidian District, Beijing 100036, China.
Xudong LuCollege of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, Zhejiang 31002, China.
Huilong DuanCollege of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, Zhejiang 31002, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropsychological testing is an effective means for the screening of Alzheimer's disease. Multiple neuropsychological rating scales should be used together to get subjects' comprehensive cognitive state due to the limitation of a single scale, but it is difficult to operate in primary clinical settings because of the inadequacy of time and qualified clinicians. Aiming at identifying AD's stages more accurately and conveniently in screening, we proposed a computer-aided diagnosis approach based on critical items extracted from multiple neuropsychological scales. The proposed hybrid intelligent approach combines the strengths of rough sets, genetic algorithm, and Bayesian network. There are two stages: one is attributes reduction technique based on rough sets and genetic algorithm, which can find out the most discriminative items for AD diagnosis in scales; the other is uncertain reasoning technique based on Bayesian network, which can forecast the probability of suffering from AD. The experimental data set consists of 500 cases collected by a top hospital in China and each case is determined by the expert panel. The results showed that the proposed approach could not only reduce items drastically with the same classification precision, but also perform better on identifying different stages of AD comparing with other existing scales.

Indexed as

AgedAged, 80 and overAlgorithmsAlzheimer DiseaseBayes TheoremChinaCognitionCognition DisordersComputer SimulationDiagnosis, Computer-AssistedFemaleHospitalizationHumansMaleMiddle AgedNeuropsychological Tests

Identifiers

PMID25815043
PMCPMC4359840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.